• Explore /
  • Poster
  • / Phase 1b study to assess the safety of neoadjuvant trifluridine/tipiracil with concurrent radiation in resectable stage II/III rectal cancer.

Phase 1b study to assess the safety of neoadjuvant trifluridine/tipiracil with concurrent radiation in resectable stage II/III rectal cancer.

Abstract Poster

Authors

null

Emerson Yu-sheng Chen

Oregon Health & Science University, Portland, OR;

Emerson Yu-sheng Chen , Nima Nabavizadeh , Daniel Herzig , Elena Korngold , Adel Kardosh , Guillaume Joe Pegna , Kenneth Gregory Bensch , Eric C. Anderson , Vassiliki Liana Tsikitis , Kim Lu , Skye C. Mayo , Brian Brinkerhoff , Shaun Goodyear , Melissa Wong , Anne Fahlman , Erin Taber , Johnson Vo , Charles R. Thomas Jr., Charles D. Lopez

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04104139

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr TPS274)

DOI

10.1200/JCO.2023.41.4_suppl.TPS274

Abstract #

TPS274

Poster Bd #

P16

Abstract Disclosures

Similar Posters

First Author: Jesse Joshua Smith

First Author: Jun Watanabe

First Author: Cesar Gregorio Muñoz

First Author: Aiwen WU